newsfilter
← Latest News
GlobeNewswire·

Nkarta to Participate in H.C. Wainwright 4th Annual Cell Therapy Virtual Conference

  • Nkarta, Inc. (NASDAQ: NKTX) will participate in H.C. Wainwright's 4th Annual Cell Therapy Virtual Conference.
  • President Nadir Mahmood will present a fireside chat at 2 p.m. ET on Tuesday, June 30, 2026.
  • The presentation will provide updates on Nkarta's investigational CAR-NK cell therapy for B cell-mediated autoimmune diseases.
  • A webcast of the event will be accessible via the investors section of Nkarta's website, with a replay archived for approximately 90 days.
  • Nkarta develops allogeneic, off-the-shelf NK cell therapies designed to eliminate pathogenic B cells using the innate immune system.
  • The company's CAR-NK cells offer on-demand availability & outpatient dosing to allow patients to access treatment in community health settings.